Hypertension pulmonaire associée aux maladies du coeur gauche: quelle définition et quelle prise en charge en 2013 [Pulmonary hypertension in left heart disease: how to define it and how to manage it in 2013?].

Details

Ressource 1Request a copy Sous embargo indéterminé.
State: Public
Version: author
Serval ID
serval:BIB_0C03C28820C3
Type
Article: article from journal or magazin.
Publication sub-type
Review (review): journal as complete as possible of one specific subject, written based on exhaustive analyses from published work.
Collection
Publications
Institution
Title
Hypertension pulmonaire associée aux maladies du coeur gauche: quelle définition et quelle prise en charge en 2013 [Pulmonary hypertension in left heart disease: how to define it and how to manage it in 2013?].
Journal
Revue Médicale Suisse
Author(s)
Yerly P., Aebischer N., Prella M., Aubert J.D., Nicod L., Vachiéry J.L.
ISSN
1660-9379 (Print)
ISSN-L
1660-9379
Publication state
Published
Issued date
2013
Volume
9
Number
388
Pages
1160-1167
Language
french
Notes
Publication types: English Abstract ; Journal Article Publication Status: ppublish
Abstract
Pulmonary hypertension is a frequent complication of left heart disease arising from a wide range of cardiac disorders and is associated with poor prognosis. Its pathophysiology is complex with both passive mechanisms of elevated filling pressures in left cavities and occasionally reactive mechanisms of arterial vasoconstriction and remodelling to interplay. This stage, called <out-of-proportions> pulmonary hypertension, further worsens the heart failure patients' prognosis but is still a matter of debate concerning the criteria to apply for its diagnosis and concerning the best way to manage it. This article gives an overview of the importance and pathophysiology of pulmonary hypertension associated with left heart disease, and discusses the challenges associated with its diagnosis and treatment.
Keywords
Diagnostic Techniques, Cardiovascular/trends, Heart Diseases/complications, Heart Diseases/diagnosis, Humans, Hypertension, Pulmonary/classification, Hypertension, Pulmonary/diagnosis, Models, Biological, Phosphodiesterase 5 Inhibitors/therapeutic use, Ventricular Dysfunction, Left/complications
Pubmed
Create date
19/09/2013 20:21
Last modification date
07/06/2021 15:09
Usage data